200,170$
0,58%
Echtzeit-Aktienkurs Steris PLC
Bid:
Ask:
Echtzeit-Chart der Steris PLC Aktie
Börsenkurse Steris PLC
| New York | - | - | - | - | 200,170$ | 0,58% |
| Tradegate | - | - | - | - | 187,500€ | 0,00% |
| Lang & Schwarz | - | - | - | - | 187,500€ | 0,00% |
Fundamentaldaten der Steris PLC Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2023 [USD] | 4,96 Mrd. | 157,35 Mio. | 107,03 Mio. | 1,07 | 0,92% | 187,43 | 3,98 |
| 2022 [USD] | 4,59 Mrd. | 314,50 Mio. | 243,89 Mio. | 2,48 | 0,84% | 80,71 | 4,37 |
| 2021 [USD] | 3,11 Mrd. | 517,53 Mio. | 397,40 Mio. | 4,63 | 0,78% | 43,27 | 5,50 |
| 2020 [USD] | 3,03 Mrd. | 498,68 Mio. | 407,61 Mio. | 4,76 | 0,72% | 42,05 | 5,61 |
| 2019 [USD] | 2,78 Mrd. | 369,47 Mio. | 304,05 Mio. | 3,56 | 0,66% | 56,26 | 6,08 |
| 2018 [USD] | 2,62 Mrd. | 354,98 Mio. | 290,92 Mio. | 3,39 | 0,60% | 59,05 | 6,47 |
| 2017 [USD] | 2,61 Mrd. | 184,65 Mio. | 109,97 Mio. | 1,28 | 0,54% | 156,38 | 6,51 |
| 2016 [USD] | 2,24 Mrd. | 171,88 Mio. | 110,76 Mio. | 1,56 | 0,49% | 128,31 | 7,68 |
| 2015 [USD] | 1,85 Mrd. | 208,82 Mio. | 135,06 Mio. | 2,25 | 0,45% | 88,96 | 6,46 |
| 2014 [USD] | 1,62 Mrd. | 188,38 Mio. | 129,44 Mio. | 2,17 | 0,41% | 92,24 | 7,28 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der Steris PLC Aktie
STERIS Plc engages in the provision of healthcare and life science products and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment offers a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Dublin, Ireland.